Answers are grounded in this paper and cite their sources.
Case of cutaneous rosai-dorfman disease following covid-19 vaccination demonstrates its complexity and rarity.
Rosai-Dorfman disease is an uncommon proliferation of non-Langerhans cell histiocytosis that mainly affects lymph nodes, although occasionally it can be associated or even present solely with extranodal involvement including skin and subcutaneous fat infiltration. We present a case of cutaneous Rosai-Dorfman disease that occurred at the site of administration of COVID-19 vaccine. The patient was a 13-year-old Bahraini girl who presented with a 1-year history of left upper arm pain and swelling that started after receiving the Pfizer vaccination for COVID-19. Clinically, the mass was medium-sized, tender, and nonmobile. Ultrasound and magnetic resonance imaging were suspicious for sarcoma. Ultrasound-guided biopsy revealed “subcutaneous panniculitis.” Excision of the mass revealed a multinodular infiltrate of the subcutaneous fat composed of distinctive large histiocytes, with characteristic emperipolesis, positive for S100, CD68, and OCT-2, consistent with Rosai-Dorfman disease. We present a case of cutaneous Rosai-Dorfman disease as a complication of COVID-19 vaccination that was challenging for the pathologist, radiologist, and clinician.
No takes yet. Share an insight, caveat, or question.
Harb et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: